Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4178661000168113 | Skyrizi (risankizumab 75 mg / 0.83 mL) injection, 2 x 0.83 mL syringes (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4178671000168119 | Skyrizi 75 mg/0.83 mL injection, 2 x 0.83 mL syringes | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Skyrizi 75 mg/0.83 mL injection, 2 x 0.83 mL syringes | Is a | Skyrizi 75 mg/0.83 mL injection, 2 x 0.83 mL syringes | true | Inferred relationship | Some | ||
| Skyrizi 75 mg/0.83 mL injection, 2 x 0.83 mL syringes | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Skyrizi 75 mg/0.83 mL injection, 2 x 0.83 mL syringes | has TPUU | Skyrizi 75 mg/0.83 mL injection, 0.83 mL syringe | true | Inferred relationship | Some | 1 | |
| Skyrizi 75 mg/0.83 mL injection, 2 x 0.83 mL syringes | has container type | syringe | true | Inferred relationship | Some | ||
| Skyrizi 75 mg/0.83 mL injection, 2 x 0.83 mL syringes | has TP | Skyrizi | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Black Triangle Scheme reference set
Containered trade product pack reference set
FHIR